Dacarbazine, a chemotherapy drug used to treat certain types of cancer, has become an essential part of the oncology treatment landscape. It is primarily used to treat Hodgkin's lymphoma and malignant melanoma. As a cytotoxic agent, it works by inhibiting DNA synthesis in cancer cells, thereby preventing their growth and proliferation.
The Dacarbazine Market is expected to increase at a...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian